Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 547

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Diagnostic Performance of Magnetic Resonance Elastography in Staging Liver Fibrosis: A Systematic Review and Meta-analysis of Individual Participant Data

Open access
Singh, Siddharth, Venkatesh, Sudhakar K., Wang, Zhen, Miller, Frank H., Motosugi, Utaroh, Low, Russell N., Hassanein, Tarek, Asbach, Patrick, Godfrey, Edmund M., Yin, Meng, Chen, Jun, Keaveny, Andrew P., Bridges, Mellena, Bohte, Anneloes, Murad, Mohammad Hassan, Lomas, David J., Talwalkar, Jayant A., Ehman, Richard L.·2015·Clinical Gastroenterology and Hepatology

Abstract

Background & Aims Magnetic resonance elastography (MRE) is a non-invasive tool for staging liver fibrosis. We conducted a meta-analysis of individual participant data collected from published studies to assess the diagnostic accuracy of MRE and for staging liver fibrosis in patients with chronic liver diseases (CLD). Methods Through a systematic literature search of multiple databases (2003–2013), we identified studies on diagnostic performance of MRE for staging liver fibrosis in patients with CLD with native anatomy, using liver biopsy as the standard. We contacted study authors to collect data on each participant’s age, sex, body mass index (BMI), liver stiffness (measured by MRE), fibrosis stage, staging system used, degree of inflammation, etiology of CLD, and interval between MRE and biopsy. Through pooled analysis, we calculated the cluster-adjusted area under receiver-operating curve (AUROC), sensitivity, and specificity of MRE for any fibrosis (≥stage 1), significant fibrosis (≥stage 2), advanced fibrosis (≥stage 3), and cirrhosis (stage 4) Results We analyzed data from 12 retrospective studies, comprising 697 patients (mean age, 55±13 years; 59.4% male; mean BMI, 26.9±6.7 kg/m2; 92.1% with <1 year interval between MRE and biopsy; hepatitis C in 47.1%). Participants had fibrosis stages 0, 1, 2, 3, or 4 (19.5%, 19.4%, 15.5%, 15.9% and 29.7%, respectively). Mean AUROC values (and 95% confidence intervals) for diagnosis of any (≥stage 1), significant (≥stage 2), or advanced fibrosis (≥stage 3), and cirrhosis, were 0.84 (0.76–0.92), 0.88 (0.84–0.91), 0.93 (0.90–0.95), and 0.92 (0.90–0.94), respectively. Similar diagnostic performance was observed in stratified analysis based on sex, obesity, and etiology of CLD. The overall rate of failure of MRE was 4.3%. Conclusion Based on pooled analysis of data from individual participants, MRE has high accuracy for diagnosis of significant or advanced fibrosis and cirrhosis, independent of BMI and etiology of CLD. Prospective studies are warranted to better understand the diagnostic performance of MRE.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cgh.2014.09.046

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 50 references

Cited by

See all 547

Metadata

Authors
Singh, S., Venkatesh, S. K., Wang, Z., Miller, F. H., Motosugi, U., Low, R. N., Hassanein, T., Asbach, P., Godfrey, E. M., Yin, M., Chen, J., Keaveny, A. P., Bridges, M., Bohte, A., Murad, M. H., Lomas, D. J., Talwalkar, J. A., & Ehman, R. L.
Venue
Clinical Gastroenterology and Hepatology
Publisher
Elsevier BV
Published
2015-03
Volume
13
Issue
3
Pages
440-451.e6
ISSN
1542-3565 (ISSN-L)
OpenAlex
W2086719465
Cited by
547
References
50
FWCI
5.29
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Diagnostic Performance of Magnetic Resonance Elastography in Staging Liver Fibrosis: A Systematic Review and Meta-analysis of Individual Participant Data. https://app.cochat.ai/papers/10.1016/j.cgh.2014.09.046
The paper
Singh, S., Venkatesh, S. K., Wang, Z., Miller, F. H., Motosugi, U., Low, R. N., Hassanein, T., Asbach, P., Godfrey, E. M., Yin, M., Chen, J., Keaveny, A. P., Bridges, M., Bohte, A., Murad, M. H., Lomas, D. J., Talwalkar, J. A., & Ehman, R. L. (2015). Diagnostic Performance of Magnetic Resonance Elastography in Staging Liver Fibrosis: A Systematic Review and Meta-analysis of Individual Participant Data. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2014.09.046

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.